Classification:
Polyclonal
Gene Alias:
cancer/testis antigen 45-1, Cancer/testis antigen 45-3, cancer/testis antigen 45-4, cancer/testis antigen 45-4/6, cancer/testis antigen 45-5, Cancer/testis antigen 45-6, cancer/testis antigen 45A1, Cancer/testis antigen 45A10, cancer/testis antigen 45A3, Cancer/testis antigen 45A4, cancer/testis antigen 45A4/45A6, cancer/testis antigen 45A5, Cancer/testis antigen 45A6, Cancer/testis antigen 45A7, cancer/testis antigen CT45-1, cancer/testis antigen CT45-3, cancer/testis antigen CT45-5, cancer/testis antigen CT45-6, cancer/testis antigen family 45 member A1, Cancer/testis antigen family 45 member A10, cancer/testis antigen family 45 member A3, Cancer/testis antigen family 45 member A4, cancer/testis antigen family 45 member A4/A6, cancer/testis antigen family 45 member A5, Cancer/testis antigen family 45 member A6, Cancer/testis antigen family 45 member A7, cancer/testis antigen family 45 member A-like, cancer/testis antigen family 45, member A1, cancer/testis antigen family 45, member A
Purification Method:
Affinity Chromatography
Gene ID (Entrez):
102723631, 441519, 441521, 541465, 541466
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Applications:
Western Blot
Concentration:
4.22 mg/mL
Formulation:
PBS with 50% glycerol and 0.01% thimerosal, pH 7.3
Gene Accession No.:
P0DMU7, P0DMU8, P0DMU9, Q5HYN5, Q8NHU0
Gene Symbols:
CT45A1, CT45A10, CT45A3, CT45A5, CT45A6
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 1-189 of human CT45A3 (NP_0010174351)
Primary or Secondary:
Primary
Target Species:
Human, Mouse, Rat